Cargando…
Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
Phosphoenolpyruvate carboxykinase 1 (PEPCK1) is the critical enzyme for gluconeogenesis and is linked with type II diabetes. Previous studies have found that SIRT2, a deacetylase, plays an important role in deacetylating PEPCK1 and little is known about the anti-diabetic activity of SIRT2 inhibitors...
Autores principales: | Zhang, Mingming, Pan, Yida, Dorfman, Robert G., Yin, Yuyao, Zhou, Qian, Huang, Shan, Liu, Jie, Zhao, Shimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428341/ https://www.ncbi.nlm.nih.gov/pubmed/28127057 http://dx.doi.org/10.1038/s41598-017-00035-9 |
Ejemplares similares
-
Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
por: Yin, Yuyao, et al.
Publicado: (2017) -
SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism()()
por: Li, Yang, et al.
Publicado: (2018) -
Downregulation of SIRT2 Inhibits Invasion of Hepatocellular Carcinoma by Inhibiting Energy Metabolism()
por: Huang, Shan, et al.
Publicado: (2017) -
Gluconeogenesis and PEPCK are critical components of healthy aging and dietary restriction life extension
por: Onken, Brian, et al.
Publicado: (2020) -
The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
por: Xu, Lei, et al.
Publicado: (2019)